Prevalence of coexistent airways obstruction in patients with cardiac disease Source: Eur Respir J 2004; 24: Suppl. 48, 278s Year: 2004
The study of the damage degree of myocardial coronary blood flow in patients with chronic obstructive pulmonary disease and severe bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008
Ivabradine prevents salbutamol-induced disturbance of cardiac autonomic regulation in patients with chronic obstructive pulmonary disease and coronary heart disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
The assessment of lung function and residual hypoxemia after balloon pulmonary angioplasty for patients with non-operable chronic thromboembolic hypertension Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020
Lung diffusion capacity is reduced in patients with coronary artery disease and no signs of heart failure Source: Eur Respir J 2006; 28: Suppl. 50, 406s Year: 2006
Changes of pulmonary artery distensibility in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 416s Year: 2001
Cardiovascular diseases: congenital, cardiogenic pulmonary oedema, mitral stenosis, chronic heart failure and myocardial infarction Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=290 Year: 2005
Cardiointervalography in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2005; 26: Suppl. 49, 509s Year: 2005
Exercise right heart catheterisation before and after pulmonary endarterectomy in patients with chronic thromboembolic disease Source: Eur Respir J, 52 (3) 1800458; 10.1183/13993003.00458-2018 Year: 2018
Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension Source: Annual Congress 2010 - COPD: management Year: 2010
Respiratory event hospitalizations are reduced in heart failure patients with comorbid chronic obstructive pulmonary disease using a wireless implanted pulmonary artery pressure monitoring system Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers Year: 2012
The frequency of the cardiac arrhythmias of the patients who suffer from the chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 509s Year: 2005
Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure Source: International Congress 2019 – More and more COPD Year: 2019
Cardiac effects of tiotropium bromide in patients with chronic obstructive pulmonary disease and coronary artery disease Source: Eur Respir J 2006; 28: Suppl. 50, 213s Year: 2006
Noninvasive identification of left-sided heart failure in a population suspected of pulmonary arterial hypertension Source: Eur Respir J 2015; 46: 422-430 Year: 2015
The frequency of combination of chronic obstructive pulmonary disease and coronary artery disease Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006
Pulmonary hypertension in left heart, respiratory and trombo-embolic pulmonary disease Source: International Congress 2015 – Pulmonary hypertension Year: 2015
Pulmonary hypertension by right heart catheterization in patients with interstitial lung diease Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017
Evaluation of pulmonary functions in valvular heart disease Source: Eur Respir J 2002; 20: Suppl. 38, 407s Year: 2002
Impact of a wireless implanted pulmonary artery pressure monitoring system in heart failure patients with comorbid chronic obstructive pulmonary disease Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012